Status:
UNKNOWN
The Effects of Synbiotic on Cardiovascular and Bone Metabolism Markers in Transplanted Kidney Patients
Lead Sponsor:
National Nutrition and Food Technology Institute
Conditions:
Transplanted Kidney
Eligibility:
All Genders
16-75 years
Phase:
NA
Brief Summary
The aim of this double-blind randomized clinical trial is to determine the effects of synbiotic supplement on cardiovascular disease risk factors and bone metabolism markers and depression, in transpl...
Eligibility Criteria
Inclusion
- : More than one year has passed since the last kidney transplant
- Having serum creatinine less than 2.5 mg/dL in the last three months
- Being in the age range of 18-75 years
- BMI\<35 kg/m2
Exclusion
- Receiving synbiotic supplement
Key Trial Info
Start Date :
December 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2024
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT06160830
Start Date
December 1 2023
End Date
May 1 2024
Last Update
December 7 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.